Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$790M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$649M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$257M |
| 4 |
Amazon
AMZN
|
+$211M |
| 5 |
Vanguard Total Bond Market
BND
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$487M |
| 2 |
Microsoft
MSFT
|
+$287M |
| 3 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$162M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$144M |
| 5 |
Donaldson
DCI
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.38% |
| 2 | Healthcare | 7.44% |
| 3 | Financials | 7.25% |
| 4 | Industrials | 6.34% |
| 5 | Consumer Discretionary | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
4901
DELISTED
NanoString Technologies, Inc.
NSTG
| $75K | ﹤0.01% |
100,214
+927
| +0.9% | +$979 |
|
|
SWZ
4902
Swiss Helvetia Fund
SWZ
$77.5M
| $74.8K | ﹤0.01% |
9,124
+4,501
| +97% | +$34.3K |
|
4903
Vanda Pharmaceuticals
VNDA
$302M
| $74.7K | ﹤0.01% |
17,700
+3,170
| +22% | +$12.8K |
|
4904
XPeng
XPEV
$11.6B
| $74.6K | ﹤0.01% |
5,114
-1,690
| -25% | -$26.9K |
|
4905
Annexon
ANNX
$886M
| $74.6K | ﹤0.01% |
16,432
+5,214
| +46% | +$12.9K |
|
4906
Birkenstock
BIRK
$7.07B
| $74.4K | ﹤0.01% |
+1,527
| New | +$66.1K |
|
4907
GraniteShares Gold Shares
BAR
$1.46B
| $74.3K | ﹤0.01% |
3,644
+1,362
| +60% | +$26.6K |
|
|
EMF
4908
Templeton Emerging Markets Fund
EMF
$326M
| $74.2K | ﹤0.01% |
6,357
-9,887
| -61% | -$113K |
|
4909
Nature's Sunshine
NATR
$288M
| $74.2K | ﹤0.01% |
4,293
+802
| +23% | +$13.9K |
|
4910
RE/MAX Holdings
RMAX
$242M
| $74.2K | ﹤0.01% |
5,566
+279
| +5% | +$3.06K |
|
4911
VanEck CEF Muni Income ETF
XMPT
$220M
| $74.2K | ﹤0.01% |
3,502
+2,001
| +133% | +$39.5K |
|
|
WPS
4912
DELISTED
iShares International Developed Property ETF
WPS
| $74.1K | ﹤0.01% |
2,586
-488
| -16% | -$12.7K |
|
|
NVTA
4913
DELISTED
Invitae Corporation
NVTA
| $74K | ﹤0.01% |
118,098
-11,779
| -9% | -$7.04K |
|
4914
Norwood Financial Corp
NWFL
$368M
| $73.8K | ﹤0.01% |
2,243
+420
| +23% | +$11.8K |
|
4915
Riley Exploration Permian
REPX
$758M
| $73.4K | ﹤0.01% |
2,696
-586
| -18% | -$16.5K |
|
4916
Atea Pharmaceuticals
AVIR
$420M
| $73.4K | ﹤0.01% |
24,064
+4,612
| +24% | +$14K |
|
4917
FS Bancorp
FSBW
$320M
| $73.3K | ﹤0.01% |
1,982
+400
| +25% | +$12.6K |
|
4918
Asure Software
ASUR
$250M
| $73.2K | ﹤0.01% |
7,689
+2,318
| +43% | +$19.4K |
|
4919
Verrica Pharmaceuticals
VRCA
$87.3M
| $72.5K | ﹤0.01% |
990
+423
| +75% | +$17.4K |
|
|
SRTA
4920
Strata Critical Medical Inc
SRTA
$512M
| $72.4K | ﹤0.01% |
20,499
+3,697
| +22% | +$10.6K |
|
|
GRCL
4921
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $72.2K | ﹤0.01% |
7,194
+440
| +7% | +$2K |
|
|
WBND
4922
DELISTED
Western Asset Total Return ETF
WBND
| $72K | ﹤0.01% |
3,480
-220
| -6% | -$4.32K |
|
4923
CF Bankshares
CFBK
$236M
| $71.7K | ﹤0.01% |
3,675
-4
| -0.1% | -$66 |
|
|
MRSN
4924
DELISTED
Mersana Therapeutics
MRSN
| $71.5K | ﹤0.01% |
1,233
+312
| +34% | +$12.6K |
|
|
YMAB
4925
DELISTED
Y-mAbs Therapeutics
YMAB
| $71.2K | ﹤0.01% |
10,433
+2,202
| +27% | +$12.7K |
|
Similar funds
Wells Fargo's Q4 2023 Portfolio in Review
As of Q4 2023, Wells Fargo held 7,882 positions worth $383B, up 12% from $341B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wells Fargo's Q4 2023 filing shows 408 new, 3,686 increased, 2,463 reduced and 394 closed positions. Its largest new stake was FT Vest US Equity Buffer ETF April: 1,231,825 shares worth $43.1M. The largest sale was Invesco QQQ Trust, an estimated $487M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- Wells Fargo's largest Q4 2023 buy was FT Vest US Equity Buffer ETF April: 1,231,825 shares worth $43.1M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $790M increase.
- Wells Fargo's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $487M.
- Wells Fargo fully exited Activision Blizzard in Q4 2023, selling an estimated $65.2M.
- Wells Fargo's ten largest holdings make up 18% of its $383B portfolio in Q4 2023.
- Wells Fargo opened 408 new positions and closed 394 in Q4 2023.
- Wells Fargo's portfolio value rose 12% quarter-over-quarter to $383B.
Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.